221 related articles for article (PubMed ID: 7499324)
41. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
Green SA; Holt BD; Liggett SB
Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
[TBL] [Abstract][Full Text] [Related]
42. Pleiotropic beta-agonist-promoted receptor conformations and signals independent of intrinsic activity.
Swift SM; Schwarb MR; Mihlbachler KA; Liggett SB
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):236-43. PubMed ID: 16980553
[TBL] [Abstract][Full Text] [Related]
43. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
44. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation.
Hebert TE; Moffett S; Morello JP; Loisel TP; Bichet DG; Barret C; Bouvier M
J Biol Chem; 1996 Jul; 271(27):16384-92. PubMed ID: 8663163
[TBL] [Abstract][Full Text] [Related]
45. Regulation of beta-adrenergic receptors by guanyl-5'-yl imidodiphosphate and other purine nucleotides.
Lefkowitz RJ; Mullikin D; Caron MG
J Biol Chem; 1976 Aug; 251(15):4686-92. PubMed ID: 947904
[TBL] [Abstract][Full Text] [Related]
46. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
[TBL] [Abstract][Full Text] [Related]
47. Agonist-induced changes in beta-adrenergic receptors on intact cells.
Toews ML; Perkins JP
J Biol Chem; 1984 Feb; 259(4):2227-35. PubMed ID: 6142040
[TBL] [Abstract][Full Text] [Related]
48. Study of interaction between agonists and asn293 in helix VI of human beta(2)-adrenergic receptor.
Zuurmond HM; Hessling J; Blüml K; Lohse M; Ijzerman AP
Mol Pharmacol; 1999 Nov; 56(5):909-16. PubMed ID: 10531394
[TBL] [Abstract][Full Text] [Related]
49. Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations.
Chen S; Lin F; Xu M; Riek RP; Novotny J; Graham RM
Biochemistry; 2002 May; 41(19):6045-53. PubMed ID: 11993999
[TBL] [Abstract][Full Text] [Related]
50. Agonist regulation of beta-adrenergic receptors: immunoblotting and indirect immunofluorescence reveal agonist-induced lateral sequestration and loss of binding.
Wang HY; Liao JF; Malbon CC
Chin J Physiol; 1996; 39(2):83-93. PubMed ID: 8902307
[TBL] [Abstract][Full Text] [Related]
51. Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes.
Zhong H; Guerrero SW; Esbenshade TA; Minneman KP
Mol Pharmacol; 1996 Jul; 50(1):175-84. PubMed ID: 8700111
[TBL] [Abstract][Full Text] [Related]
52. Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists.
Swaminath G; Deupi X; Lee TW; Zhu W; Thian FS; Kobilka TS; Kobilka B
J Biol Chem; 2005 Jun; 280(23):22165-71. PubMed ID: 15817484
[TBL] [Abstract][Full Text] [Related]
53. Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling.
Manglik A; Kim TH; Masureel M; Altenbach C; Yang Z; Hilger D; Lerch MT; Kobilka TS; Thian FS; Hubbell WL; Prosser RS; Kobilka BK
Cell; 2015 May; 161(5):1101-1111. PubMed ID: 25981665
[TBL] [Abstract][Full Text] [Related]
54. Fluorescence detection of ligand binding to labeled cytochrome P450 BM3.
Ferrero VE; Di Nardo G; Catucci G; Sadeghi SJ; Gilardi G
Dalton Trans; 2012 Feb; 41(7):2018-25. PubMed ID: 22180859
[TBL] [Abstract][Full Text] [Related]
55. Evolving concepts of partial agonism. The beta-adrenergic receptor as a paradigm.
Jasper JR; Insel PA
Biochem Pharmacol; 1992 Jan; 43(2):119-30. PubMed ID: 1346741
[TBL] [Abstract][Full Text] [Related]
56. beta 2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein rap1 and the serine/threonine kinase B-Raf.
Schmitt JM; Stork PJ
J Biol Chem; 2000 Aug; 275(33):25342-50. PubMed ID: 10840035
[TBL] [Abstract][Full Text] [Related]
57. New molecular and structural determinants involved in beta 2-adrenergic receptor desensitization and sequestration. Delineation using chimeric beta 3/beta 2-adrenergic receptors.
Jockers R; Da Silva A; Strosberg AD; Bouvier M; Marullo S
J Biol Chem; 1996 Apr; 271(16):9355-62. PubMed ID: 8621600
[TBL] [Abstract][Full Text] [Related]
58. The olfactory G protein G(alphaolf) possesses a lower GDP-affinity and deactivates more rapidly than G(salphashort): consequences for receptor-coupling and adenylyl cyclase activation.
Liu HY; Wenzel-Seifert K; Seifert R
J Neurochem; 2001 Jul; 78(2):325-38. PubMed ID: 11461968
[TBL] [Abstract][Full Text] [Related]
59. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
